TAZTIA

×

Overview

What is TAZTIA?

Rx Only

Diltiazem hydrochloride, USP is a calcium ion cellular influx inhibitor (slow channel blocker). Chemically, diltiazem hydrochloride is 1,5-Benzothiazepin-4(5)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2, 3-dihydro-2-(4-methoxyphenyl)-, monohydrochloride, (+)--. The chemical structure is:

Diltiazem hydrochloride, USP is a white to off-white crystalline powder with a bitter taste. It is soluble in water, methanol and chloroform and has a molecular weight of 450.98. Diltiazem hydrochloride extend-release capsules, USP (once-a-day dosage) contain diltiazem hydrochloride in extended-release pellets at doses of 120, 180, 240, 300 and 360 mg.

Diltiazem hydrochloride extend-release capsules, USP (once-a-day dosage) also contains: black iron oxide, corn starch, ethylcellulose, D&C Yellow #10 Aluminum Lake, FD&C Blue #1 Aluminum Lake, FD&C Blue #2 Aluminum Lake, FD&C Red #40 Aluminum Lake, gelatin, hypromellose 2910, magnesium stearate, nonoxynol 100, pharmaceutical glaze, polysorbate 80, polyacrylic dispersion, povidone, propylene glycol, sucrose, talc and titanium dioxide. The 120 mg capsules also contain: D&C Red #28, FD&C Blue #1 and FD&C Red #40. The 180 mg capsules also contain: D&C Yellow #10, FD&C Blue #1 and FD&C Yellow #6. The 240 mg capsules also contain: D&C Red #28, FD&C Blue #1 and FD&C Red #40. The 300 mg capsules also contain: D&C Red #28, D&C Yellow #10, FD&C Blue #1, FD&C Red #40 and FD&C Yellow #6. The 360 mg capsules also contain: FD&C Blue #1.

For oral administration.

Meets USP requirements for dissolution test 15.

What does TAZTIA look like?

What are the available doses of TAZTIA?

Sorry No records found.

What should I talk to my health care provider before I take TAZTIA?

Sorry No records found

How should I use TAZTIA?

Diltiazem hydrochloride extended-release capsules (Once-a-Day Dosage) are indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive medications.

Hypertension:

Angina:

Concomitant use with Other Cardiovascular Agents:

1. Sublingual Nitroglycerin (NTG):

2. Prophylactic Nitrate Therapy:

3. Beta-blockers:

4. Antihypertensives:

Hypertensive or anginal patients who are treated with other formulations of diltiazem can safely be switched to diltiazem hydrochloride extend-release capsules (once-a-day dosage) at the nearest equivalent total daily dose. Subsequent titration to higher or lower doses may, however, be necessary and should be initiated as clinically indicated.

Sprinkling the Capsule Contents on Food:

Diltiazem hydrochloride extended-release capsules (once-a-day-dosage) may also be administered by carefully opening the capsule and sprinkling the capsule contents on a spoonful of applesauce. The applesauce should be swallowed immediately without chewing and followed with a glass of cool water to ensure complete swallowing of the capsule contents. The applesauce should not be hot, and it should be soft enough to be swallowed without chewing. Any capsule contents/applesauce mixture should be used immediately and not stored for future use. Subdividing the contents of a diltiazem hydrochloride extended-release capsule (once-a-day-dosage) is not recommended.

What interacts with TAZTIA?

Sorry No Records found

What are the warnings of TAZTIA?

Photosensitivity manifested by an exaggerated sunburn reaction has been observed in some individuals taking tetracyclines. Patients apt to be exposed to direct sunlight or ultraviolet light should be advised that this reaction can occur with tetracycline drugs, and treatment should be discontinued at the first evidence of skin erythema.

1. Cardiac Conduction:

2. Congestive Heart Failure:

3. Hypotension:

What are the precautions of TAZTIA?

Array

General

Diltiazem hydrochloride is extensively metabolized by the liver and excreted by the kidneys and in bile. As with any drug given over prolonged periods, laboratory parameters of renal and hepatic function should be monitored at regular intervals. The drug should be used with caution in patients with impaired renal or hepatic function. In subacute and chronic dog and rat studies designed to produce toxicity, high doses of diltiazem were associated with hepatic damage. In special subacute hepatic studies, oral doses of 125 mg/kg and higher in rats were associated with histological changes in the liver which were reversible when the drug was discontinued. In dogs, doses of 20 mg/kg were also associated with hepatic changes; however, these changes were reversible with continued dosing.

Dermatological events (see ) may be transient and may disappear despite continued use of diltiazem hydrochloride. However, skin eruptions progressing to erythema multiforme and/or exfoliative dermatitis have also been infrequently reported. Should a dermatologic reaction persist, the drug should be discontinued.

Array

Drug Interactions

Due to the potential for additive effects, caution and careful titration are warranted in patients receiving diltiazem hydrochloride concomitantly with other agents known to affect cardiac contractility and/or conduction (see ). Pharmacologic studies indicate that there may be additive effects in prolonging AV conduction when using beta-blockers or digitalis concomitantly with diltiazem hydrochloride extended-release capsules (once-a-day dosage) (see ). As with all drugs, care should be exercised when treating patients with multiple medications. Diltiazem is both a substrate and an inhibitor of the cytochrome P450 3A4 enzyme system. Other drugs that are specific substrates, inhibitors, or inducers of the enzyme system may have a significant impact on the efficacy and side effect profile of diltiazem. Patients taking other drugs that are substrates of CYP450 3A4, especially patients with renal and/or hepatic impairment, may require dosage adjustment when starting or stopping concomitantly administered diltiazem in order to maintain optimum therapeutic blood levels.

Anesthetics:

Array

Array

Buspirone:

Carbamazepine:

Cimetidine:

Clonidine:

Cyclosporine:

The effect of cyclosporine on diltiazem plasma concentrations has not been evaluated.

Digitalis:

Ivabradine:

Quinidine:

Rifampin:

Statins:

In a healthy volunteer cross-over study (N=10), coadministration of a single 20 mg dose of simvastatin at the end of a 14-day regimen with 120 mg BID diltiazem SR resulted in a 5-fold increase in mean simvastatin AUC versus simvastatin alone. Subjects with increased average steady-state exposures of diltiazem showed a greater increase in simvastatin exposure. If coadministration of simvastatin with diltiazem is required, limit the daily doses of simvastatin to 10 mg and diltiazem to 240 mg.

In a ten-subject randomized, open-label, 4-way cross-over study, coadministration of diltiazem (120 mg BID diltiazem SR for 2 weeks) with a single 20 mg dose of lovastatin resulted in 3- to 4-fold increase in mean lovastatin AUC and C versus lovastatin alone. In the same study, there was no significant change in 20 mg single dose pravastatin AUC and C during diltiazem coadministration. Diltiazem plasma levels were not significantly affected by lovastatin or pravastatin.

Array

Carcinogenesis, Mutagenesis, Impairment of Fertility

A 24-month study in rats at oral dosage levels of up to 100 mg/kg/day and a 21-month study in mice at oral dosage levels of up to 30 mg/kg/day showed no evidence of carcinogenicity. There was also no mutagenic response or in mammalian cell assays or in bacteria. No evidence of impaired fertility was observed in a study performed in male and female rats at oral dosages of up to 100 mg/kg/day.

Array

Pregnancy

Reproduction studies have been conducted in mice, rats, and rabbits. Administration of doses ranging from 4 to 6 times (depending on species) the upper limit of the optimum dosage range in clinical trials (480 mg/day or 8 mg/kg/day for a 60-kg patient) resulted in embryo and fetal lethality. These studies revealed, in one species or another, a propensity to cause abnormalities of the skeleton, heart, retina, and tongue. Also observed were reductions in early individual pup weights and pup survival, prolonged delivery and increased incidence of stillbirths. There are no well-controlled studies in pregnant women; therefore, use diltiazem hydrochloride in pregnant women only if the potential benefit justifies the potential risk to the fetus.

Array

Nursing Mothers

Diltiazem is excreted in human milk. One report suggests that concentrations in breast milk may approximate serum levels. If use of diltiazem hydrochloride extended-release capsules (once-a-day dosage) is deemed essential, an alternative method of infant feeding should be instituted.

Array

Pediatric Use

Safety and effectiveness in children have not been established.

Array

Geriatric Use

Clinical studies of diltiazem did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

What are the side effects of TAZTIA?

Sorry No records found

What should I look out for while using TAZTIA?

Diltiazem is contraindicated in:

1. Cardiac Conduction:

2. Congestive Heart Failure:

3. Hypotension:

4. Acute Hepatic Injury:

What might happen if I take too much TAZTIA?

The oral LD50’s in mice and rats range from 415 to 740 mg/kg and from 560 to 810 mg/kg, respectively. The intravenous LD50’s in these species were 60 and 38 mg/kg, respectively. The oral LD50 in dogs is considered to be in excess of 50 mg/kg, while lethality was seen in monkeys at 360 mg/kg.

The toxic dose in man is not known. Due to extensive metabolism, blood levels after a standard dose of diltiazem can vary over tenfold, limiting the usefulness of blood levels in overdose cases. There have been 29 reports of diltiazem overdose in doses ranging from less than 1 gm to 10.8 gm. Sixteen of these reports involved multiple drug ingestions. Twenty-two reports indicated patients had recovered from diltiazem overdose ranging from less than 1 gm to 10.8 gm. There were seven reports with a fatal outcome; although the amount of diltiazem ingested was unknown, multiple drug ingestions were confirmed in six of the seven reports.

Events observed following diltiazem overdose included bradycardia, hypotension, heart block, and cardiac failure. Most reports of overdose described some supportive medical measure and/or drug treatment. Bradycardia frequently responded favorably to atropine as did heart block, although cardiac pacing was also frequently utilized to treat heart block. Fluids and vasopressors were used to maintain blood pressure, and in cases of cardiac failure, inotropic agents were administered. In addition, some patients received treatment with ventilatory support, activated charcoal, and/or intravenous calcium. Evidence of the effectiveness of intravenous calcium administration to reverse the pharmacological effects of diltiazem overdose was conflicting.

In the event of overdose or exaggerated response, appropriate supportive measures should be employed in addition to gastrointestinal decontamination. Diltiazem does not appear to be removed by peritoneal or hemodialysis. Based on the known pharmacological effects of diltiazem and/or reported clinical experiences, the following measures may be considered:

Bradycardia:

High-Degree AV Block:

Cardiac Failure:

Hypotension:

In a few reported cases, overdose with calcium channel blockers has been associated with hypotension and bradycardia, initially refractory to atropine but becoming more responsive to this treatment when the patients received large doses (close to 1 gram/hour for more than 24 hours) of calcium chloride.

Due to extensive metabolism, plasma concentrations after a standard dose of diltiazem can vary over tenfold, which significantly limits their value in evaluation cases of overdosage.

Charcoal hemoperfusion has been used successfully as an adjunct therapy to hasten drug elimination. Overdoses with as much as 10.8 gm of oral diltiazem have been successfully treated using appropriate supportive care.

How should I store and handle TAZTIA?

Store at 20° to 25°C (68° to 77°F). Protect from light. It is recommended that the infusion bags be kept in the overwrap until ready to use. Protect infusion bags from freezing.Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].Gabapentin capsules, USP are supplied as follows:100 mg capsules:White hard gelatin capsules printed with “137” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-137-02 Non Child Resistant Cap ------------------------------------ NDC 62756-137-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-137-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-137-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-137-01300 mg capsules:Yellow hard gelatin capsules printed with “138” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------NDC 62756-138-02 Non Child Resistant Cap ------------------------------------ NDC 62756-138-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-138-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-138-04Unit dose 50's: ----------------------------------------------------------------------NDC 62756-138-01400 mg capsules:Orange hard gelatin capsules printed with “139” on cap and body; available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-139-02 Non Child Resistant Cap ------------------------------------ NDC 62756-139-03Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-139-05Bottles of 1000: Non Child Resistant Cap ------------------------------------ NDC 62756-139-04Unit dose 50's: ---------------------------------------------------------------------- NDC 62756-139-01Gabapentin tablets, USP are supplied as follows:600 mg tablets:White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “202” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-202-01 Non Child Resistant Cap ------------------------------------ NDC 62756-202-02Bottles of 500: Non Child Resistant Cap------------------------------------ NDC 62756-202-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-202-04800 mg tablets;White to off white, biconvex, oval shaped, film-coated tablet scored on both sides and debossed with “204” on one side, available in:Bottles of 100: Child Resistant Cap ------------------------------------------ NDC 62756-204-01 Non Child Resistant Cap ------------------------------------ NDC 62756-204-02Bottles of 500: Non Child Resistant Cap ------------------------------------ NDC 62756-204-03Unit dose 50’s: --------------------------------------------------------------------- NDC 62756-204-04StorageStore at 20° to 25°C (68 to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [See USP Controlled Room Temperature].

×

Clinical Information

Chemical Structure

No Image found

Clinical Pharmacology

Hypertension:

Angina:

Diltiazem has been shown to be a potent dilator of coronary arteries, both epicardial and subendocardial. Spontaneous and ergonovine-induced coronary artery spasms are inhibited by diltiazem.

In animal models, diltiazem interferes with the slow inward (depolarizing) current in excitable tissue. It causes excitation-contraction uncoupling in various myocardial tissues without changes in the configuration of the action potential. Diltiazem produces relaxation of the coronary vascular smooth muscle and dilation of both large and small coronary vascular smooth muscle and dilation of both large and small coronary arteries at drug levels which cause little or no negative inotropic effect. The resultant increases in coronary blood flow (epicardial and subendocardial) occur in ischemic and nonischemic models and are accompanied by dose-dependent decreases in systemic blood pressure and decreases in peripheral resistance.

Non-Clinical Toxicology

Diltiazem is contraindicated in:

1. Cardiac Conduction:

2. Congestive Heart Failure:

3. Hypotension:

4. Acute Hepatic Injury:

Due to the potential for additive effects, caution and careful titration are warranted in patients receiving diltiazem hydrochloride concomitantly with other agents known to affect cardiac contractility and/or conduction (see ). Pharmacologic studies indicate that there may be additive effects in prolonging AV conduction when using beta-blockers or digitalis concomitantly with diltiazem hydrochloride extended-release capsules (once-a-day dosage) (see ). As with all drugs, care should be exercised when treating patients with multiple medications. Diltiazem is both a substrate and an inhibitor of the cytochrome P450 3A4 enzyme system. Other drugs that are specific substrates, inhibitors, or inducers of the enzyme system may have a significant impact on the efficacy and side effect profile of diltiazem. Patients taking other drugs that are substrates of CYP450 3A4, especially patients with renal and/or hepatic impairment, may require dosage adjustment when starting or stopping concomitantly administered diltiazem in order to maintain optimum therapeutic blood levels.

Anesthetics:

Buspirone:

Carbamazepine:

Cimetidine:

Clonidine:

Cyclosporine:

The effect of cyclosporine on diltiazem plasma concentrations has not been evaluated.

Digitalis:

Ivabradine:

Quinidine:

Rifampin:

Statins:

In a healthy volunteer cross-over study (N=10), coadministration of a single 20 mg dose of simvastatin at the end of a 14-day regimen with 120 mg BID diltiazem SR resulted in a 5-fold increase in mean simvastatin AUC versus simvastatin alone. Subjects with increased average steady-state exposures of diltiazem showed a greater increase in simvastatin exposure. If coadministration of simvastatin with diltiazem is required, limit the daily doses of simvastatin to 10 mg and diltiazem to 240 mg.

In a ten-subject randomized, open-label, 4-way cross-over study, coadministration of diltiazem (120 mg BID diltiazem SR for 2 weeks) with a single 20 mg dose of lovastatin resulted in 3- to 4-fold increase in mean lovastatin AUC and C versus lovastatin alone. In the same study, there was no significant change in 20 mg single dose pravastatin AUC and C during diltiazem coadministration. Diltiazem plasma levels were not significantly affected by lovastatin or pravastatin.

Diltiazem hydrochloride is extensively metabolized by the liver and excreted by the kidneys and in bile. As with any drug given over prolonged periods, laboratory parameters of renal and hepatic function should be monitored at regular intervals. The drug should be used with caution in patients with impaired renal or hepatic function. In subacute and chronic dog and rat studies designed to produce toxicity, high doses of diltiazem were associated with hepatic damage. In special subacute hepatic studies, oral doses of 125 mg/kg and higher in rats were associated with histological changes in the liver which were reversible when the drug was discontinued. In dogs, doses of 20 mg/kg were also associated with hepatic changes; however, these changes were reversible with continued dosing.

Dermatological events (see ) may be transient and may disappear despite continued use of diltiazem hydrochloride. However, skin eruptions progressing to erythema multiforme and/or exfoliative dermatitis have also been infrequently reported. Should a dermatologic reaction persist, the drug should be discontinued.

Serious adverse reactions have been rare in studies with diltiazem hydrochloride extended-release capsules (once-a-day dosage), as well as with other diltiazem formulations. It should be recognized that patients with impaired ventricular function and cardiac conduction abnormalities have usually been excluded from these studies. A total of 256 hypertensives were treated for between 4 and 8 weeks; a total of 207 patients with chronic stable angina were treated for 3 weeks with doses of diltiazem hydrochloride extended-release capsules (once-a-day dosage) ranging from 120 to 540 mg once daily. Two patients experienced first-degree AV block at the 540 mg dose. The following table presents the most common adverse reactions, whether or not drug-related, reported in placebo-controlled trials in patients receiving diltiazem hydrochloride extended-release capsules (once-a-day dosage) up to 360 mg and up to 540 mg with rates in placebo patients shown for comparison.

*Adverse events occurring in treated patients at 2% or more than placebo-treated patients.

In addition, the following events have been reported infrequently (less than 2%) in clinical trials with other diltiazem products:

Cardiovascular:

Nervous System:

Gastrointestinal:

Dermatological:

Other:

In addition, the following postmarketing events have been reported infrequently in patients receiving diltiazem hydrochloride: acute generalized exanthematous pustulosis, alopecia, erythema multiforme, exfoliative dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, extrapyramidal symptoms, gingival hyperplasia, hemolytic anemia, increased bleeding time, photosensitivity (including lichenoid keratosis and hyperpigmentation at sun-exposed skin areas), leukopenia, purpura, retinopathy, and thrombocytopenia. In addition, events such as myocardial infarction have been observed which are not readily distinguishable from the natural history of the disease in these patients. A number of well-documented cases of generalized rash, characterized as leukocytoclastic vasculitis, have been reported. However, a definitive cause and effect relationship between these events and diltiazem hydrochloride therapy is yet to be established.

To report SUSPECTED ADVERSE EVENTS, contact Actavis at 1-800-272-5525 or FDA at 1-800-FDA-1088 or for voluntary reporting of adverse reactions.

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Review

×

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72

×

Tips

×

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).

Disclaimer:

Overview

What is TAZTIA?

What does TAZTIA look like?

What are the available doses of TAZTIA?

What should I talk to my health care provider before I take TAZTIA?

How should I use TAZTIA?

What interacts with TAZTIA?

What are the warnings of TAZTIA?

What are the precautions of TAZTIA?

What are the side effects of TAZTIA?

What should I look out for while using TAZTIA?

What might happen if I take too much TAZTIA?

How should I store and handle TAZTIA?

Clinical Information

Chemical Structure

Clinical Pharmacology

Non-Clinical Toxicology

Reference

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

Review

Rate this treatment and share your opinion

Helpful tips to write a good review:

Reason for Taking This Treatment

Click the stars to rate this treatment

Effectiveness (required)

Ease of Use (required)

Satisfaction (required)

Write a brief description of your experience with this treatment:

Optional Information

User Reviews & Ratings - losartan oral

«losartan oral Information

Overall User Ratings

User Reviews
Learn about User Reviews

Related to losartan oral

Professional

Tips

Interactions

Follow Us Here

Disclaimer:

TAZTIA

Overview

What is TAZTIA?

What does TAZTIA look like?

What are the available doses of TAZTIA?

What should I talk to my health care provider before I take TAZTIA?

How should I use TAZTIA?

What interacts with TAZTIA?

What are the warnings of TAZTIA?

What are the precautions of TAZTIA?

What are the side effects of TAZTIA?

What should I look out for while using TAZTIA?

What might happen if I take too much TAZTIA?

How should I store and handle TAZTIA?

Clinical Information

Chemical Structure

Clinical Pharmacology

Non-Clinical Toxicology

Reference

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

Review

Rate this treatment and share your opinion

Helpful tips to write a good review:

Reason for Taking This Treatment

Click the stars to rate this treatment

Effectiveness (required)

Ease of Use (required)

Satisfaction (required)

Write a brief description of your experience with this treatment:

Optional Information

User Reviews & Ratings - losartan oral

«losartan oral Information

Overall User Ratings

User Reviews Learn about User Reviews

Related to losartan oral

Professional

Tips

Interactions

Follow Us Here

User Reviews
Learn about User Reviews